Simeprevir Production Cost Reports

The report provides a detailed analysis essential for establishing a simeprevir production plant. It encompasses all critical aspects necessary for simeprevir production, including the cost of simeprevir production, simeprevir plant cost, simeprevir production costs, and the overall simeprevir production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a simeprevir production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Simeprevir is a medication that targets the hepatitis C virus (HCV)  by blocking a protein the virus needs to copy itself. It is approved for adults with compensated liver disease, including cirrhosis. It is also used in combination with peginterferon alfa and ribavirin. It clears the virus long-term, called sustained virologic response, to prevent liver failure or cancer. It works best without the Q80K mutation in genotype 1a, and its treatment lasts 12 weeks in simpler combos but up to 48 weeks otherwise. Its common side effects include rash (including photosensitivity), itching (pruritus), nausea, headache, fatigue, diarrhoea, dizziness, muscle pain (myalgia), and shortness of breath (dyspnoea).

The market for simeprevir is driven by its usage as a direct-acting antiviral for higher efficacy, shorter durations, and broader genotype coverage. Its demand in Europe and emerging markets for affordable combination therapies (e.g., with sofosbuvir) contributes to its market growth. The rise in cases of HCV and guideline inclusions for specific compensated liver disease fuel its market. The high pricing pressures from generics and biosimilars, strict regulatory genotyping requirements and supply chain dependencies on certain suppliers affect industrial simeprevir procurement. Also, reimbursement problems in cost-constrained regions and competition eroding branded volumes post-patent expiry impact its market dynamics.

Raw Material for Simeprevir Production

According to the simeprevir production plant project report, the key raw materials used in the production of simeprevir include diene precursors, metal metathesis catalyst, and solvents.

Production Process of Simeprevir

The extensive simeprevir production cost report consists of the following major industrial production process:

1. From diene precursors: The production process of simeprevir involves a multi-step process. First, hydrolysis of diene precursors with LiOH in THF and water takes place. This is followed by coupling with a carboxylic acid derivative using EEDQ in an organic solvent. The ring-closing metathesis (RCM) of the diene precursor with a metal catalyst in toluene forms the 14-membered macrocycle. The final hydrolysis of the ester with NaOH in methanol and ethanol at controlled temperature, followed by acidification, extraction, and crystallization gives the sodium salt of simeprevir as the final product.

Simeprevir is a white to off-white solid that has poor aqueous solubility and high permeability. It has the molecular formula C38H47N5O7S2 and a molecular weight of 749.94 g/mol (average) or 749.29 g/mol (monoisotopic). It has an XLogP3 value of 4.8, which makes it highly lipophilic. It has a topological polar surface area of 194 Ų with 2 hydrogen bond donors, 10 acceptors, 8 rotatable bonds, and 52 heavy atoms. It has a complexity of 1490, a formal charge of 0, a physiological charge of -1, with a basic pKa around 1.61. It is stored as a solid at -20 degrees Celsius for stability, consistent with its solubility profile, suitable for organic solvent use in synthesis.